Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/41224
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorHernández Ruiz, Orville-
dc.contributor.authorde Almeida Soares, Célia Maria-
dc.contributor.authorBorges, Clayton Luiz-
dc.contributor.authorDias, Fátima Ribeiro-
dc.contributor.authorElias Moreira, André Luís-
dc.contributor.authorMattos, Karine-
dc.contributor.authorMilhomem Cruz Leite, Vanessa Rafaela-
dc.contributor.authorMorais Inácio, Moisés-
dc.contributor.authorO’Hara Souza Silva, Lana-
dc.contributor.authorSchneider Weber, Simone-
dc.contributor.authorVenturini, James-
dc.date.accessioned2024-08-18T19:14:19Z-
dc.date.available2024-08-18T19:14:19Z-
dc.date.issued2023-
dc.identifier.citationInácio MM, Moreira ALE, Cruz-Leite VRM, Mattos K, Silva LOS, Venturini J, Ruiz OH, Ribeiro-Dias F, Weber SS, Soares CMA, Borges CL. Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics. J Fungi (Basel). 2023 May 31;9(6):633. doi: 10.3390/jof9060633.spa
dc.identifier.urihttps://hdl.handle.net/10495/41224-
dc.description.abstractABSTRACT: Fungal infections represent a serious global health problem, causing damage to health and the economy on the scale of millions. Although vaccines are the most effective therapeutic approach used to combat infectious agents, at the moment, no fungal vaccine has been approved for use in humans. However, the scientific community has been working hard to overcome this challenge. In this sense, we aim to describe here an update on the development of fungal vaccines and the progress of methodological and experimental immunotherapies against fungal infections. In addition, advances in immunoinformatic tools are described as an important aid by which to overcome the difficulty of achieving success in fungal vaccine development. In silico approaches are great options for the most important and difficult questions regarding the attainment of an efficient fungal vaccine. Here, we suggest how bioinformatic tools could contribute, considering the main challenges, to an effective fungal vaccine.spa
dc.format.extent35 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherMDPIspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.titleFungal Vaccine Development: State of the Art and Perspectives Using Immunoinformaticsspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupBiología Celular y Molecular CIB U. de A. U. del Rosariospa
dc.publisher.groupGrupo de Investigación en Microbiología Básica y Aplicada-Microbaspa
dc.identifier.doi10.3390/jof9060633-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn2309-608X-
oaire.citationtitleJournal of Fungispa
oaire.citationstartpage1spa
oaire.citationendpage35spa
oaire.citationvolume9spa
oaire.citationissue6spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
oaire.fundernameConselho Nacional de Desenvolvimento Científico e Tecnológicospa
oaire.fundernameInstitutos Nacionais de Ciência e Tecnologiaspa
oaire.fundernameFundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sulspa
oaire.fundernameCoordenação de Aperfeicoamento de Pessoal de Nível Superiorspa
dc.publisher.placeBasilea, Suizaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bcspa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTREVspa
dc.type.localArtículo de revisiónspa
dc.subject.decsBiología Computacional-
dc.subject.decsComputational Biology-
dc.subject.decsHongos-
dc.subject.decsFungi-
dc.subject.decsVacunas-
dc.subject.decsVaccines-
dc.subject.decsEnfermedades Desatendidas-
dc.subject.decsNeglected Diseases-
dc.subject.decsMicosis-
dc.subject.decsMycoses-
dc.identifier.urlhttps://www.mdpi.com/journal/jofspa
dc.description.researchgroupidCOL0000963spa
dc.description.researchgroupidCOL0126131spa
oaire.awardnumberEdital Universal-CNPq- 408042/2021-4spa
oaire.awardnumberFUNDECT/DECIT-MS/CNPq/SES No. 03/2016-PPSUS-MS, PPSUS/FUNDECT No. 08/2020spa
oaire.awardnumberCAPES 001spa
oaire.awardnumberCAPES 88882.458447/2019-01spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D019295-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D005658-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D014612-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D058069-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D009181-
dc.relation.ispartofjournalabbrevJ. Fungi.spa
oaire.funderidentifier.rorRoR:03swz6y49-
oaire.funderidentifier.rorRoR:045ydbe97-
oaire.funderidentifier.rorRoR:05jtrt935-
oaire.funderidentifier.rorRoR:00x0ma614-
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
RuizHernandezOrville_2023_Bioinformatic_Vaccine_Fungi.pdfArtículo de revisión1.81 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons